Oded Grinstein
CEO
Claimed by owner Simplivia Healthcare
Former names: Monfort Medical
Closed-system Transfer Device for Safe Compounding and Administration
Acquired by FIMI Opportunity Funds on May, 2019
Simplivia Healthcare
www.calcalist.co.il
•
Feb 10, 2022
פימי תנפיק את סימפליויה בשווי של פי 7 לעומת הרכישה מטבע כלכליסט
en.globes.co.il
•
Jan 5, 2021
Simplivia Healthcare buys diagnostics co Novamed
en.globes.co.il
•
Oct 22, 2020
FIMI sells 33% of medical equipment co Simplivia
en.globes.co.il
•
May 1, 2019
FIMI completes acquisition of Teva's Kiryat Shmona plant
About
Simplivia Healthcare develops and manufactures high-quality drug-delivery solutions to ensure the safety of healthcare professionals.
Simplivias Tevadaptor and Chemfort products use the companys patented Toxi-Guard system, located in the vial adaptor, to allow pressure equalization during use, preventing the escape of hazardous drug vapors into the environment during drug reconstitution and administration as well as preventing airborne contaminants and particles from entering the drug vial.
Tevadaptor was formerly a business unit in Teva Pharmaceutical Industries. In May 2019, Simplivia Healthcare incorporated Tevadaptor after the business unit was acquired by FIMI Opportunity Funds, an Israeli private equity firm.
In the U.S., Simplivias products are distributed exclusively by B. Braun under the brand name OnGuard. Tevadaptor and Chemfort are approved by the worlds leading regulatory bodies. The companys manufacturing facility in Kiryat Shmona, Israel, meets the most rigorous standards, with both FDA and CE approval.
Simplivias Tevadaptor and Chemfort products use the companys patented Toxi-Guard system, located in the vial adaptor, to allow pressure equalization during use, preventing the escape of hazardous drug vapors into the environment during drug reconstitution and administration as well as preventing airborne contaminants and particles from entering the drug vial.
Tevadaptor was formerly a business unit in Teva Pharmaceutical Industries. In May 2019, Simplivia Healthcare incorporated Tevadaptor after the business unit was acquired by FIMI Opportunity Funds, an Israeli private equity firm.
In the U.S., Simplivias products are distributed exclusively by B. Braun under the brand name OnGuard. Tevadaptor and Chemfort are approved by the worlds leading regulatory bodies. The companys manufacturing facility in Kiryat Shmona, Israel, meets the most rigorous standards, with both FDA and CE approval.
Primary Sector
Life Sciences & HealthTech
Products
Chemfort, Toxi-Guard, Tevadaptor
Geographic markets
Global
Funding
Total Funding
Undisclosed
Last Funding
Undisclosed
Funding Stage
Total Rounds
0
Investors
0
News
(4)
www.calcalist.co.il
•
Feb 10, 2022
פימי תנפיק את סימפליויה בשווי של פי 7 לעומת הרכישה מטבע כלכליסט
en.globes.co.il
•
Jan 5, 2021
Simplivia Healthcare buys diagnostics co Novamed
en.globes.co.il
•
Oct 22, 2020
FIMI sells 33% of medical equipment co Simplivia
en.globes.co.il
•
May 1, 2019
FIMI completes acquisition of Teva's Kiryat Shmona plant
The Team
(4)
OG
DR
Dima Rainer
CCO
DD
David Delouya
CFO
DG
Dana German
Marketing Communications Manager
Connect with
What is the reason for connecting?
Your company *
Your position *
Add invitation message
0/300
Sending invitation...
Company Lifecycle
Public Offerings & Exits
M&A
EXIT
$47.5M
May 2019
Type
Acquisition
Was acquired by
FIMI Opportunity Funds
$47.5M
Mergers and Acquisitions
M&A
Undisclosed
Jan 2021
Type
Acquisition
Acquired
Novamed
Undisclosed
Media gallery
(2)
About Tevadaptor closed system transfer device
Locations
Israel
Northern Industrial Zone, Kiryat Shmona, Israel
Locations
Israel
Northern Industrial Zone, Kiryat Shmona, Israel
Unlock financial data
Finder is provided for free by the non-profit organization Start-Up Nation Central.
- Get unlimited search results
- Save to custom lists - Smartlists
- Get notified with news and updates
- Connect with people
And much more...
I already have access,